sweating from his neck to his waist only on his left side; metallic taste in his mouth when got the vaccine; felt like he was coming down with something, like he didn't feel like himself, like he had a fever.; nose was blocked like he had a severe cold; felt like he was coming down with something, like he didn't feel like himself, like he had a fever.; sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore left arm), HYPERHIDROSIS (sweating from his neck to his waist only on his left side), DYSGEUSIA (metallic taste in his mouth when got the vaccine), FEELING ABNORMAL (felt like he was coming down with something, like he didn't feel like himself, like he had a fever.) and NASOPHARYNGITIS (nose was blocked like he had a severe cold) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007821A and 046821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis since 01-Jan-2002, Allergy to animal (Soft shell-clam), Penicillin allergy, Drug allergy (Tetanus anti-toxin), Contrast media allergy, Blood pressure management since 15-Dec-2018, Gout since 15-Apr-1997 and Hypercholesteraemia since 15-Dec-2018. Concomitant products included SPIRONOLACTONE from 15-Dec-2018 to an unknown date for Blood pressure management, ALLOPURINOL from 15-Apr-1997 to an unknown date for Gout, ROSUVASTATIN from 15-Dec-2018 to an unknown date for High cholesterol, METOPROLOL, ASPIRIN [ACETYLSALICYLIC ACID] from 15-Apr-1997 to an unknown date, FISH OIL, UBIDECARENONE (COQ) from 15-Apr-1997 to an unknown date, NAPROXEN SODIUM (ALEVE) and CINNAMOMUM CASSIA BARK, THIOCTIC ACID (CINNAMON ALPHA LIPOIC ACID) for an unknown indication.   On 22-Mar-2021 at 1:15 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021 at 1:15 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore left arm), DYSGEUSIA (metallic taste in his mouth when got the vaccine), FEELING ABNORMAL (felt like he was coming down with something, like he didn't feel like himself, like he had a fever.), NASOPHARYNGITIS (nose was blocked like he had a severe cold) and PYREXIA (felt like he was coming down with something, like he didn't feel like himself, like he had a fever.). On 23-Mar-2021, the patient experienced HYPERHIDROSIS (sweating from his neck to his waist only on his left side). On 22-Mar-2021, NASOPHARYNGITIS (nose was blocked like he had a severe cold) had resolved. On 23-Mar-2021, DYSGEUSIA (metallic taste in his mouth when got the vaccine), FEELING ABNORMAL (felt like he was coming down with something, like he didn't feel like himself, like he had a fever.) and PYREXIA (felt like he was coming down with something, like he didn't feel like himself, like he had a fever.) had resolved. At the time of the report, PAIN IN EXTREMITY (sore left arm) had not resolved and HYPERHIDROSIS (sweating from his neck to his waist only on his left side) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No adverse events occurred after second dose.  No treatment medication was not reported.  Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Patient demographics updated, medical history information updated, dosage and route of administration for concomitant medications added, second dose of vaccine added.